Lista de obras -

Cholesterol-lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial

artículo científico publicado en 2020

Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure

scientific article published on 01 August 2011

Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial

article by Cristiane C K Mayerhofer et al published 1 October 2018 in ESC Heart Failure

Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension

artículo científico publicado en 2020

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

artículo científico publicado en 2016

Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction

artículo científico publicado en 2017

Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality

artículo científico publicado en 2009

Galectin-3 in heart failure: high levels are associated with all-cause mortality ⬇️

artículo científico publicado el 8 de junio de 2011

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure

artículo científico publicado en 2017

Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure

artículo científico publicado en 2015

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

scientific article published on 29 June 2018

Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages

scientific article published on 14 December 2019

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

artículo científico publicado en 2017

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

artículo científico publicado en 2020

NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome

artículo científico publicado en 2012

Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)

artículo científico publicado en 2019

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

artículo científico publicado en 2012

Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy

artículo científico publicado en 2017

Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure

artículo científico publicado en 2014

The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy

artículo científico publicado en 2017

The alternative complement pathway is dysregulated in patients with chronic heart failure

artículo científico publicado en 2017

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection

artículo científico publicado en 2019

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial

artículo científico publicado en 2014

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

artículo científico publicado en 2017

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T

artículo científico publicado en 2018

Lista de obras de

Cholesterol-lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial

Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure

Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial

Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction

Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality

Galectin-3 in heart failure: high levels are associated with all-cause mortality ⬇️

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure

Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome

Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis

Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy

Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure

The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy

The alternative complement pathway is dysregulated in patients with chronic heart failure

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T